News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Harley-Davidson CEO Artie Starrs recently purchased 10,000 shares of company stock for $258,900, increasing his stake by 66.67% to 25,000 shares. This insider buying follows the company's strong quarterly results, which surpassed EPS and revenue estimates, though revenue saw a slight year-over-year decline. Despite …
Sharemaestro market context Trend signal active 52 weeks +14.6%Charles River Laboratories International Inc. (CRL) saw its stock advance by 1.81% to $282.00 on Tuesday, marking its sixth consecutive day of gains. This performance stood out on a generally grim trading day where the S&P 500 Index fell 0.32% and the Dow Jones …
Charles River Laboratories International Director James Foster sold 28,733 shares of NYSE:CRL stock for approximately $7.9 million at an average price of $275, reducing his direct ownership by 47.63%. This transaction, conducted under a pre-arranged Rule 10b5-1 trading plan, comes amidst generally positive analyst …
Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL), reported a bona fide gift of 257 shares of common stock on August 10, 2026. This transaction was a disposition at a reported per-share price of $0.00, leaving LaPlume …
Charles River Laboratories International director James C. Foster exercised stock options for 28,733 shares at $179.66 per share and immediately sold them at $275.00 per share on August 10, 2026, pursuant to a Rule 10b5-1 Trading Plan. This transaction resulted in an approximate pre-tax …
This SEC filing (Form 144) for Charles River Laboratories International, Inc. (CRL) details a proposed sale of 6,500 shares of common stock, valued at $1,819,350.00, acquired through the exercise of stock options on August 11, 2026. The transaction was handled by UBS Financial Services, …
Donald Smith & Co., Inc., along with DSCO Value Fund, L.P., has reported a beneficial ownership of 9,279,072 shares of Harley-Davidson, Inc. (HOG) common stock, which represents 8.81% of the class as of June 30, 2026. Donald Smith & Co. holds sole voting power …
Sun Harley-Davidson, Colorado's original Harley-Davidson dealership, is celebrating its 50th anniversary and the grand reopening of its renovated showroom on Saturday, August 22, 2026. The event will feature live music, food trucks, giveaways, and the chance to win a new 2026 Harley-Davidson Street Glide, …
Michael Knell, SVP, Finance and Chief Accounting Officer at Charles River Laboratories International (NASDAQ:CRL), sold 6,645 shares totaling approximately $1.73 million on August 6, 2026, with prices ranging from $258.53 to $265.17 per share. On the same day, he acquired 2,345 shares through stock …
Bulldog Harley-Davidson, an independent dealership in Smithfield, North Carolina, has successfully implemented Revmo AI to manage inbound calls across its sales, service, and parts departments. In its first eight weeks, Revmo AI answered nearly 1,200 calls, booked 69 appointments, and recovered an estimated $37,000 …
Charles Schwab Trust Co. has acquired 21,725 shares of Mondelez International (MDLZ) in the second quarter, valued at approximately $1.26 million, contributing to the 78.32% institutional ownership of the stock. Analysts generally maintain a "Moderate Buy" rating with an average target price of $67.30, …
Charles Schwab Trust Co. has acquired 5,282 shares of RTX Corporation, valued at approximately $1.0 million, during the second quarter, making it a new position for the institutional investor. RTX Corporation recently reported strong quarterly earnings, beating analyst estimates with $1.89 adjusted EPS and …
Charles Schwab Trust Co significantly increased its stake in Amgen Inc. by 678.3% in the second quarter, now holding 7,464 shares valued at $2.7 million. This comes as institutional investors collectively own 76.5% of Amgen's stock, and the company reported strong quarterly earnings, beating …
Charles Schwab Trust Co significantly increased its stake in Philip Morris International (PM) by 636.8% in the second quarter, purchasing 15,704 additional shares, bringing its total holdings to 18,170 shares valued at $3.29 million. Philip Morris reported strong quarterly results, surpassing expectations with an …
Charles Schwab Trust Co significantly increased its stake in ExxonMobil Corporation (NYSE:XOM) by 392.9% in the second quarter, purchasing an additional 97,424 shares and bringing its total holdings to 122,223 shares valued at $16.71 million. Institutional investors now own 61.80% of ExxonMobil's stock. The …
Charles Schwab Trust Co significantly increased its holdings in Invesco QQQ (NASDAQ:QQQ) by 85.6% in the second quarter, bringing its total to 9,175 shares valued at $6.757 million. Other institutional investors also made substantial changes to their QQQ holdings, with Bank of America Corp …
Charles River Laboratories International (NYSE:CRL) has received an average "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $255.65. This follows the company exceeding quarterly earnings expectations with an adjusted EPS of $3.02 and revenue of $1.0 billion. Despite recent …
Nigel J. Murtagh, Chief Risk Officer at Charles Schwab Corp., recently sold approximately $2.9 million worth of company stock through a pre-arranged trading plan. These sales followed his exercise of nonqualified stock options totaling over $1.2 million, after which he retains a significant holding …
Charles Schwab (NYSE:SCHW) Director Paula Sneed sold 5,263 shares of the company's stock for approximately $563,930 on August 7th, reducing her position by 5.43%. Following the sale, she retained 91,711 shares. The company recently reported strong quarterly earnings, exceeding analyst estimates, and declared a …
Charles Schwab insider Nigel Murtagh sold 24,778 shares of company stock for approximately $2.70 million. This transaction reduced his ownership by nearly 30% and was conducted under a pre-arranged Rule 10b5-1 plan. Despite the insider sale, Charles Schwab reported strong quarterly earnings, beating analyst …
Charles R. Schwab, Co-Chairman of SCHWAB CHARLES CORP (SCHW), reported a bona fide gift transfer of 37,200 common stock shares on August 6, 2026. This transaction, made indirectly through a Trust, reflects his resignation as trustee of two trusts benefiting relatives. Following the gift, …
Paula A Sneed, a director at Charles Schwab Corp. (NYSE:SCHW), recently sold 5,263 shares of company stock for approximately $563,954. The sale occurred in multiple trades with prices ranging from $107.07 to $107.205 per share, as Schwab's stock trades near its 52-week high. Following …
Nigel J. Murtagh, Chief Risk Officer at Charles Schwab, exercised nonqualified stock options for 26,675 shares at $46.81 per share and subsequently sold them at an average of $109 per share on August 6 and 10, 2026. These transactions, which generated an approximate pre-tax …
Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …
Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …
Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …
James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …
Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …
The Charles Schwab Corporation's trading activity index (STAX) showed a modest increase in July, rising to 59.80 from 59.12 in June. Schwab clients were net buyers of ETFs and equities at a two-to-one ratio, indicating continued bullish sentiment among self-directed traders.
Company Also Moving Forward With Risk Mitigation Strategies to Exit Bankruptcy as Quickly as Possible SAN JOSE, Calif. & HOUSTON, August 10, 2026--(BUSINESS WIRE)--Linqto, Inc. today announced that it continues to pursue its litigation against Forge Global, Inc. and its owner, The Charles Schwab …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from June's 59.12, indicating that Schwab clients were net buyers during late-month market dips. Gen X clients and self-directed traders showed the strongest buying interest, focusing on individual stocks, ETFs, and …
Schwab Trading Activity Index vs. S&P 500 (Graphic: Charles Schwab) Schwab clients were net buyers, using late-month dips to add exposure across individual stocks, ETFs, and options Key Takeaways: The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from its …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%Search by ticker symbol or company name and select a result to open its chart.